Showing results (1-10 of 118) with videos related to
Sort By:
Pageof 12
Gastroenterologia Y Hepatologia|July 28, 2015
Costs of ulcerative colitis from a societal perspective in a regional health care area in Spain: A database studyXavier Aldeguer, Antoni Sicras-MainarGaceta Sanitaria|October 26, 2010
[Influence of substitution of brand name for generic drugs on therapeutic compliance in hypertension and dyslipidemia]Antoni Sicras Mainar, Ruth Navarro ArtiedaThe Journal of International Medical Research|October 28, 2020
Potential interactions between pangenotypic direct-acting antivirals and concomitant cardiovascular therapies in patients with chronic hepatitis C virus infectionAntoni Sicras-Mainar, Ramón Morillo-VerdugoRevista Peruana De Medicina Experimental Y Salud Publica|January 20, 2015
[Combination therapy of metformin vs dipeptidulpeptidase inhibitors and sulfonylureas in type 2 diabetes: clinical and economic impact]Antoni Sicras-Mainar, Ruth Navarro-ArtiedaDiabetes & Metabolism Journal|March 3, 2015
Economic impact of combining metformin with dipeptidyl peptidase-4 inhibitors in diabetic patients with renal impairment in spanish patientsAntoni Sicras-Mainar, Ruth Navarro-ArtiedaAdicciones|December 18, 2020
Concomitant use of direct-acting antivirals (DAA) and central nervous system drugs in patients with hepatitis C virus infectionAntoni Sicras-Mainar, Ramón Morillo-VerdugoGaceta Sanitaria|March 10, 2009
[Validating the Adjusted Clinical Groups [ACG] case-mix system in a Spanish population setting: a multicenter study]Antoni Sicras-Mainar, Ruth Navarro-Artieda, Diabetes Technology & Therapeutics|August 5, 2014
Healthcare costs of the combination of metformin/dipeptidyl peptidase-4 inhibitors compared with metformin/other oral antidiabetes agents in patients with type 2 diabetes and metabolic syndromeAntoni Sicras-Mainar, Ruth Navarro-ArtiedaMedicina Clinica|July 15, 2009
[Cost of arterial hypertension according to levels of morbidity in primary care setting]Antoni Sicras-Mainar, Ruth Navarro-ArtiedaGaceta Sanitaria|June 7, 2006
[Measurement of relative cost weights as an effect of the retrospective application of adjusted clinical groups in primary care]Antoni Sicras-Mainar, Josep Serrat-TarrésPageof 12